Grdzelishvili VZ - Search Results

1

Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and Solutions.

Holbrook MC, Goad DW, Grdzelishvili VZ. Holbrook MC, et al. Among authors: grdzelishvili vz. Cancers (Basel). 2021 Mar 9;13(5):1171. doi: 10.3390/cancers13051171. Cancers (Basel). 2021. PMID: 33803211 Free PMC article. Review.

2

Vesicular stomatitis virus as an oncolytic agent against pancreatic ductal adenocarcinoma.

Murphy AM, Besmer DM, Moerdyk-Schauwecker M, Moestl N, Ornelles DA, Mukherjee P, Grdzelishvili VZ. Murphy AM, et al. Among authors: grdzelishvili vz. J Virol. 2012 Mar;86(6):3073-87. doi: 10.1128/JVI.05640-11. Epub 2012 Jan 11. J Virol. 2012. PMID: 22238308 Free PMC article.

3

Vesicular stomatitis virus as a flexible platform for oncolytic virotherapy against cancer.

Hastie E, Grdzelishvili VZ. Hastie E, et al. Among authors: grdzelishvili vz. J Gen Virol. 2012 Dec;93(Pt 12):2529-2545. doi: 10.1099/vir.0.046672-0. Epub 2012 Oct 10. J Gen Virol. 2012. PMID: 23052398 Free PMC article. Review.

4

Resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus: role of type I interferon signaling.

Moerdyk-Schauwecker M, Shah NR, Murphy AM, Hastie E, Mukherjee P, Grdzelishvili VZ. Moerdyk-Schauwecker M, et al. Among authors: grdzelishvili vz. Virology. 2013 Feb 5;436(1):221-34. doi: 10.1016/j.virol.2012.11.014. Epub 2012 Dec 14. Virology. 2013. PMID: 23246628 Free PMC article.

5

Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.

Hastie E, Besmer DM, Shah NR, Murphy AM, Moerdyk-Schauwecker M, Molestina C, Roy LD, Curry JM, Mukherjee P, Grdzelishvili VZ. Hastie E, et al. Among authors: grdzelishvili vz. J Virol. 2013 Sep;87(18):10283-94. doi: 10.1128/JVI.01412-13. Epub 2013 Jul 17. J Virol. 2013. PMID: 23864625 Free PMC article.

6

Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus.

Felt SA, Moerdyk-Schauwecker MJ, Grdzelishvili VZ. Felt SA, et al. Among authors: grdzelishvili vz. Virology. 2015 Jan 1;474:163-73. doi: 10.1016/j.virol.2014.10.026. Epub 2014 Nov 19. Virology. 2015. PMID: 25463614 Free PMC article.

7

Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.

Hastie E, Cataldi M, Moerdyk-Schauwecker MJ, Felt SA, Steuerwald N, Grdzelishvili VZ. Hastie E, et al. Among authors: grdzelishvili vz. Oncotarget. 2016 Sep 20;7(38):61601-61618. doi: 10.18632/oncotarget.11202. Oncotarget. 2016. PMID: 27533247 Free PMC article.

8

Combining Oncolytic Virotherapy with p53 Tumor Suppressor Gene Therapy.

Bressy C, Hastie E, Grdzelishvili VZ. Bressy C, et al. Among authors: grdzelishvili vz. Mol Ther Oncolytics. 2017 Mar 21;5:20-40. doi: 10.1016/j.omto.2017.03.002. eCollection 2017 Jun 16. Mol Ther Oncolytics. 2017. PMID: 28480326 Free PMC article. Review.

9

Ruxolitinib and Polycation Combination Treatment Overcomes Multiple Mechanisms of Resistance of Pancreatic Cancer Cells to Oncolytic Vesicular Stomatitis Virus.

Felt SA, Droby GN, Grdzelishvili VZ. Felt SA, et al. Among authors: grdzelishvili vz. J Virol. 2017 Jul 27;91(16):e00461-17. doi: 10.1128/JVI.00461-17. Print 2017 Aug 15. J Virol. 2017. PMID: 28566376 Free PMC article.

10

Recent advances in vesicular stomatitis virus-based oncolytic virotherapy: a 5-year update.

Felt SA, Grdzelishvili VZ. Felt SA, et al. Among authors: grdzelishvili vz. J Gen Virol. 2017 Dec;98(12):2895-2911. doi: 10.1099/jgv.0.000980. J Gen Virol. 2017. PMID: 29143726 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters